255 related articles for article (PubMed ID: 26860323)
1. Radiation-induced mesothelioma among long-term solid cancer survivors: a longitudinal analysis of SEER database.
Farioli A; Ottone M; Morganti AG; Compagnone G; Romani F; Cammelli S; Mattioli S; Violante FS
Cancer Med; 2016 May; 5(5):950-9. PubMed ID: 26860323
[TBL] [Abstract][Full Text] [Related]
2. Risk of mesothelioma following external beam radiotherapy for prostate cancer: a cohort analysis of SEER database.
Farioli A; Violante FS; Mattioli S; Curti S; Kriebel D
Cancer Causes Control; 2013 Aug; 24(8):1535-45. PubMed ID: 23702885
[TBL] [Abstract][Full Text] [Related]
3. Incidence of malignant pleural mesothelioma after thoracic radiotherapy.
Neugut AI; Ahsan H; Antman KH
Cancer; 1997 Sep; 80(5):948-50. PubMed ID: 9307196
[TBL] [Abstract][Full Text] [Related]
4. Post-irradiation malignant mesothelioma.
Cavazza A; Travis LB; Travis WD; Wolfe JT; Foo ML; Gillespie DJ; Weidner N; Colby TV
Cancer; 1996 Apr; 77(7):1379-85. PubMed ID: 8608519
[TBL] [Abstract][Full Text] [Related]
5. Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973-2005.
Moolgavkar SH; Meza R; Turim J
Cancer Causes Control; 2009 Aug; 20(6):935-44. PubMed ID: 19294523
[TBL] [Abstract][Full Text] [Related]
6. Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005.
Price B; Ware A
Crit Rev Toxicol; 2009; 39(7):576-88. PubMed ID: 19650718
[TBL] [Abstract][Full Text] [Related]
7. Comparison of second cancer risks from brachytherapy and external beam therapy after uterine corpus cancer.
Lönn S; Gilbert ES; Ron E; Smith SA; Stovall M; Curtis RE
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):464-74. PubMed ID: 20142245
[TBL] [Abstract][Full Text] [Related]
8. Analysis of current trends in United States mesothelioma incidence.
Price B
Am J Epidemiol; 1997 Feb; 145(3):211-8. PubMed ID: 9012593
[TBL] [Abstract][Full Text] [Related]
9. [Incidence of malignant mesothelioma (1980-1999) and asbestos exposure in 190 cases diagnosed among residents of the province of Brescia].
Barbieri PG; Lombardi S; Candela A; Pezzotti C; Binda I
Med Lav; 2001; 92(4):249-62. PubMed ID: 11676187
[TBL] [Abstract][Full Text] [Related]
10. Second solid cancers after radiotherapy for breast cancer in SEER cancer registries.
Berrington de Gonzalez A; Curtis RE; Gilbert E; Berg CD; Smith SA; Stovall M; Ron E
Br J Cancer; 2010 Jan; 102(1):220-6. PubMed ID: 19935795
[TBL] [Abstract][Full Text] [Related]
11. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
Moschini M; Zaffuto E; Karakiewicz PI; Andrea DD; Foerster B; Abufaraj M; Soria F; Mattei A; Montorsi F; Briganti A; Shariat SF
Eur Urol; 2019 Feb; 75(2):319-328. PubMed ID: 30293908
[TBL] [Abstract][Full Text] [Related]
12. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
Travis LB; Fosså SD; Schonfeld SJ; McMaster ML; Lynch CF; Storm H; Hall P; Holowaty E; Andersen A; Pukkala E; Andersson M; Kaijser M; Gospodarowicz M; Joensuu T; Cohen RJ; Boice JD; Dores GM; Gilbert ES
J Natl Cancer Inst; 2005 Sep; 97(18):1354-65. PubMed ID: 16174857
[TBL] [Abstract][Full Text] [Related]
13. [Malignant mesothelioma in Basse-Normandie, a French population study. Descriptive analysis, prognostic factors and survival].
Desoubeaux N; Bouvier V; Gervais R; Galateau-Salle F; Thibon P; Leplumey T; Herbert C; Lecherbonnier Y; Daviet JP; Letourneux M
Rev Epidemiol Sante Publique; 2001 Dec; 49(6):523-9. PubMed ID: 11845101
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic radiation for lymphoma and risk of second primary malignant mesothelioma.
Chang ET; Lau EC; Mowat FS; Teta MJ
Cancer Causes Control; 2017 Sep; 28(9):971-979. PubMed ID: 28755241
[TBL] [Abstract][Full Text] [Related]
15. The exposure-response relationship for mesothelioma among asbestos-cement factory workers.
Finkelstein MM
Toxicol Ind Health; 1990 Dec; 6(6):623-7. PubMed ID: 2097820
[TBL] [Abstract][Full Text] [Related]
16. Mesothelioma risk after 40 years since first exposure to asbestos: a pooled analysis.
Reid A; de Klerk NH; Magnani C; Ferrante D; Berry G; Musk AW; Merler E
Thorax; 2014 Sep; 69(9):843-50. PubMed ID: 24842786
[TBL] [Abstract][Full Text] [Related]
17. Differences among peritoneal and pleural mesothelioma: data from the Lombardy Region Mesothelioma Register (Italy).
Mensi C; Bonzini M; Macchione M; Sieno C; Riboldi L; Pesatori AC
Med Lav; 2011; 102(5):409-16. PubMed ID: 22022760
[TBL] [Abstract][Full Text] [Related]
18. Risk of second primary cancers after malignant mesothelioma and vice versa.
Chen T; Kharazmi E; Lou J; Zhang X; Sundquist K; Hemminki K
Cancer Lett; 2016 Aug; 379(1):94-9. PubMed ID: 27260871
[TBL] [Abstract][Full Text] [Related]
19. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
[TBL] [Abstract][Full Text] [Related]
20. US mesothelioma patterns 1973-2002: indicators of change and insights into background rates.
Teta MJ; Mink PJ; Lau E; Sceurman BK; Foster ED
Eur J Cancer Prev; 2008 Nov; 17(6):525-34. PubMed ID: 18941374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
